FDA Drug Application (202971) for ABILIFY MAINTENA KIT by OTSUKA PHARM CO LTD

Back to FDA Applications sponsored by OTSUKA PHARM CO LTD

Application Number202971
Product Number001
FormFOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage300MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABILIFY MAINTENA KIT
Active IngredientARIPIPRAZOLE



Back to FDA Applications sponsored by OTSUKA PHARM CO LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.